0001209191-12-058237.txt : 20121218
0001209191-12-058237.hdr.sgml : 20121218
20121218154755
ACCESSION NUMBER: 0001209191-12-058237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121217
FILED AS OF DATE: 20121218
DATE AS OF CHANGE: 20121218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MILLER LLOYD I III
CENTRAL INDEX KEY: 0000949119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33560
FILM NUMBER: 121271337
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Capstone Therapeutics Corp.
CENTRAL INDEX KEY: 0000887151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 860585310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
BUSINESS PHONE: 6022865520
MAIL ADDRESS:
STREET 1: 1275 WEST WASHINGTON STREET
STREET 2: SUITE 101
CITY: TEMPE
STATE: AZ
ZIP: 85281
FORMER COMPANY:
FORMER CONFORMED NAME: ORTHOLOGIC CORP
DATE OF NAME CHANGE: 19940211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-12-17
0
0000887151
Capstone Therapeutics Corp.
CAPS
0000949119
MILLER LLOYD I III
222 LAKEVIEW AVENUE
SUITE 160-365
WEST PALM BEACH
FL
33401
0
0
1
0
Common Stock
2012-12-17
4
P
0
175000
0.1607
A
4412468
I
By Trust A-4 - Lloyd I. Miller
Common Stock
472792
I
By Milfam II L.P.
Common Stock
90344
I
By Trust D - Lloyd I. Miller
Common Stock
641218
I
By Milgrat Q8
Common Stock
724100
I
By Milfam NG LLC
Common Stock
58967
D
The price in Column 4 is a weighted average price. The price actually paid ranged from $0.16 to $0.165 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.
/s/ David J. Hoyt
Attorney-in-fact
2012-12-18